Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.

Sjoquist, Katrin M; Friedlander, Michael L; O'Connell, Rachel L; Voysey, Merryn; King, Madeleine T; Stockler, Martin R; Oza, Amit M; Gillies, Kim; Martyn, Julie K; Butow, Phyllis N

Sjoquist, Katrin M; Friedlander, Michael L; O'Connell, Rachel L; Voysey, Merryn; King, Madeleine T; Stockler, Martin R; Oza, Amit M; Gillies, Kim; Martyn, Julie K; Butow, Phyllis N.

Affiliation

Sjoquist KM; Australian and New Zealand Gynaecological Oncology Group and National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia;

Oncologist ; 18(11): 1221-8, 2013.

Article in En | MEDLINE | ID: mdl-24107972

Subject(s)

Hope; Neoplasms, Glandular and Epithelial/drug therapy; Neoplasms, Glandular and Epithelial/psychology; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/psychology; Adult; Aged; Aged, 80 and over; Anxiety/etiology; Anxiety/psychology; Carcinoma, Ovarian Epithelial; Depression/etiology; Depression/psychology; Drug Resistance, Neoplasm; Female; Humans; Longitudinal Studies; Middle Aged; Neoplasm Recurrence, Local/drug therapy; Neoplasm Recurrence, Local/psychology; Organoplatinum Compounds/pharmacology; Prognosis; Quality of Life; Surveys and Questionnaires; Treatment Outcome

Key words

Chemotherapy; Hope; Recurrent ovarian cancer; Symptom benefit; Symptoms

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplasms, Glandular and Epithelial / Hope Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google